AARP Eye Center
Medicare just announced the first set of Part D drugs that will be subject to negotiation, and the resulting negotiated prices will become available in 2026.
A new law that addresses high prescription drug prices and out-of-pocket costs will help improve the affordability of insulin for millions of diabetic Medicare beneficiaries, and new research sheds light on its potential impact.
High and growing prescription drug prices will eventually affect all Americans in some way. Congress is currently considering proposals that will permit Medicare to negotiate with drug companies, as well as discourage price increases that exceed inflation.
Despite the myriad of financial challenges facing patients and all Americans, many brand name drug companies have already increased the prices of their products in 2022.
A new type of prescription drug for stroke prevention for adults with atrial fibrillation quickly replaced the existing standard treatment—even before evidence emerged to support the switch.
Fifteen years ago, President George W. Bush signed the Medicare Prescription Drug, Improvement, and Modernization Act which, among other things, created Medicare Part D to cover outpatient prescription drugs. Today, more than 40 million Americans are enrolled in Medicare Part D prescription drug…
Turing Pharmaceuticals recently faced intense public criticism after the company bought a 62-year-old drug and increased its price by 5,000 percent. Turing’s unusually outspoken chief executive officer, Martin Shkreli, strongly defended the decision, even going so far as to argue that the new price…
Lately you may have noticed a growing number of commercials filled with people happily touting the benefits of their new joints. Experts expect such procedures to become increasingly popular as the active boomer population continues to age. However, the commercials typically gloss over the fact…